• 

  Scientists reveal structural details of spike protein used in leading COVID-19 vaccine

  Electron microscopy showed that the coronavirus spikes maintained the desired shape in the vaccine, which should help stimulate an appropriate immune response.

• 

  Scientists partner with San Diego transit and health workers to study wearable devices for detecting COVID-19

  Scripps Research is collaborating with frontline workers at the San Diego Metropolitan Transit System and Scripps Health to help detect and track viral illnesses in near real-time.

• 

  Scripps Research joins national effort to develop medical record analytics to improve COVID-19 patient outcomes

  The rich data stored in electronic medical records may offer clues to better care for those diagnosed with coronavirus disease.

• 

  San Diego’s scientific and medical institutes collaborate on large-scale research program to study spread of COVID-19

  With an initial focus on screening local healthcare workers and first responders, the study seeks to understand the prevalence of coronavirus infections in the community.

• 

  Super-potent human antibodies protect against COVID-19 in animal tests

  A team led by Scripps Research has discovered antibodies in the blood of recovered COVID-19 patients that provide powerful protection against the coronavirus that causes the disease.

• 

  Mutated coronavirus shows significant boost in infectivity

  A tiny genetic mutation to the virus that causes COVID-19 leads to a significant change in the virus’ ability to infect cells, according to new research from Hyeryun Choe, PhD, and Michael Farzan, PhD.

• 

  Data scientists inventing new tools to rapidly analyze the spread, evolution of novel coronavirus

  Scripps Research is collaborating with top computational scientists at Johns Hopkins University and UCLA.

• 

  Up to 45 percent of SARS-CoV-2 infections may be asymptomatic, new analysis finds

  Analysis of data from 16 groups of COVID-19 patients suggest “silent” carriers may exacerbate efforts to stop spread of the disease

• 

  In human mini-brain experiments, drug preserves and rebuilds nerve connections that are lost to Alzheimer’s

  In experiments on human 'mini-brains,' the drug preserved nerve connections that are lost to Alzheimer’s. The drug is also being evaluated for COVID-19, as it is known to inhibit viral activity.

• 

  Antibodies produced in response to one type of coronavirus don’t offer protection against the other, study suggests

  Even though the coronaviruses that cause SARS and COVID-19 are closely related and infect cells the same way, they aren’t cross-protective in cell culture experiments.